Stonepine Capital Management, LLC
Top Portfolio Positions
69 positions ·
$379,993,799 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| RADX |
Radiopharm Theranostics Ltd
Healthcare
|
51,000,000 | $219,300,000 | 57.71% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
1,950,400 | $31,186,896 | 8.21% | |
| VSTM |
Verastem, Inc.
Healthcare
|
3,302,300 | $17,502,190 | 4.61% | |
| ADMA |
Adma Biologics, Inc.
Healthcare
|
1,890,000 | $17,028,900 | 4.48% | |
| EOLS |
Evolus, Inc.
Healthcare
|
2,179,091 | $8,956,064 | 2.36% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
1,389,622 | $6,128,233 | 1.61% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
85,000 | $6,115,750 | 1.61% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
100,000 | $5,272,000 | 1.39% | |
| ZVRA |
Zevra Therapeutics, Inc.
Healthcare
|
480,000 | $4,473,600 | 1.18% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
846,587 | $3,792,709 | 1.00% |
Portfolio Trend
25 quarters · across all stocks
Holdings in NKTR
Shares Held
Position Value (USD)
5 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,115,750 | 85,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,114,000 | 50,000 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $3,593,800 | 85,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,836,500 | 85,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,297,168 | 50,200 | Shares | Sole | 2025-08-13 | |
| No 13F history on record for this holder in this stock. | ||||||